F Fakhouri, J Zuber, V Frémeaux-Bacchi, C Loirat - The Lancet, 2017 - thelancet.com
Haemolytic uraemic syndrome is a form of thrombotic microangiopathy affecting predominantly the kidney and characterised by a triad of thrombocytopenia, mechanical …
V Brocklebank, KM Wood… - Clinical Journal of the …, 2018 - journals.lww.com
Thrombotic microangiopathy can manifest in a diverse range of diseases and is characterized by thrombocytopenia, microangiopathic hemolytic anemia, and organ injury …
DJ Arachchillage, L Mackillop… - British journal of …, 2022 - ncbi.nlm.nih.gov
Guidelines Committee and the sounding board of BSH. It was also placed on the members section of the BSH website for comment. It has also been reviewed by Royal College of …
Background Chronic kidney disease (CKD) is estimated to affect 3% of pregnant women in high-income countries,(Piccoli et al., 2018,# 13860) which equates to between 15,000 …
F Fakhouri, V Frémeaux-Bacchi - Nature Reviews Nephrology, 2021 - nature.com
Studies of complement genetics have changed the landscape of thrombotic microangiopathies (TMAs), particularly atypical haemolytic uraemic syndrome (aHUS) …
F Fakhouri, M Scully, F Provôt, M Blasco… - Blood, The Journal …, 2020 - ashpublications.org
Pregnancy and postpartum are high-risk periods for different forms of thrombotic microangiopathy (TMA). However, the management of pregnancy-associated TMA remains …
DB Cines, LD Levine - Hematology 2014, the American Society …, 2017 - ashpublications.org
Abstract Thrombocytopenia develops in 5% to 10% of women during pregnancy or in the immediate postpartum period. A low platelet count is often an incidental feature, but it might …
G Socié, MP Caby‐Tosi, JL Marantz… - British journal of …, 2019 - Wiley Online Library
Eculizumab is the first and only medication approved for paroxysmal nocturnal haemoglobinuria (PNH) and atypical haemolytic uraemic syndrome (aHUS) treatment …
Antiphospholipid syndrome (APS), an acquired autoimmune thrombophilia, is characterised by thrombosis and/or pregnancy morbidity in association with persistent antiphospholipid …